LENSAR Inc

LNSR | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.25

+$0.04 (+0.55%)

At close: Sep 22, 2026, 4:00 PM ET

$7.25

$0 (0.00%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.55%

(1D)

Rating

Updated: Sep 12, 2026

51.5

Fundamentals Average

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $89.04M

1D Range

7.13 7.30

52W Range

4.95 12.94

Valuation (TTM)

PE -21.85

PB 5.94

EV/EBITDA 2.10

Valuation (NTM)

Forward PE 116.62

Forward PEG -1.77

Price Target $13

Cash Flow

FCF Yield -8.3%

SBC Adj. FCF Yield -10.6%

SBC Impact -28.2%

Margins

Gross Margin 48.0%

Operating Margin -13.5%

FCF Margin -12.2%

Growth (CAGR)

Revenue 3Y | 5Y 16.4% | 14.7%

Dil EPS 3Y | 5Y 20.9% | 9.3%

FCF 3Y | 5Y 18.3% | 15.9%

Returns

ROA 49.9%

ROE 10380.3%

ROIC -16.0%

Financial Health

Net Cash

$11.18M

Current Ratio 2.39

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically i...

Sector Healthcare

Industry Medical - Devices

Employees 150

IPO Date Oct 1, 2020

Website www.lensar.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$13

Upside

+79.31%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞